260 related articles for article (PubMed ID: 35411416)
21. Arsenic trioxide inhibits angiogenesis of hepatocellular carcinoma after insufficient radiofrequency ablation via blocking paracrine angiopoietin-1 and angiopoietin-2.
Dong S; Li Z; Kong J; Wu S; Gao J; Sun W
Int J Hyperthermia; 2022; 39(1):888-896. PubMed ID: 35848416
[TBL] [Abstract][Full Text] [Related]
22. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
Li W; Wang M; Wang L; Ji S; Zhang J; Zhang C
Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599
[TBL] [Abstract][Full Text] [Related]
23. Periostin contributes to arsenic trioxide resistance in hepatocellular carcinoma cells under hypoxia.
Liu Y; Gao F; Song W
Biomed Pharmacother; 2017 Apr; 88():342-348. PubMed ID: 28119236
[TBL] [Abstract][Full Text] [Related]
24. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
[TBL] [Abstract][Full Text] [Related]
25. 'Prodrug-Like' Acetylmannosamine Modified Liposomes Loaded With Arsenic Trioxide for the Treatment of Orthotopic Glioma in Mice.
Wang N; Zhang W; Hu D; Jiang L; Liu X; Tang S; Zhou X; Liu T; Tang X; Chai Y; Li M; Peng H; Du Z
J Pharm Sci; 2020 Sep; 109(9):2861-2873. PubMed ID: 32534027
[TBL] [Abstract][Full Text] [Related]
26. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
Zheng T; Yin D; Lu Z; Wang J; Li Y; Chen X; Liang Y; Song X; Qi S; Sun B; Xie C; Meng X; Pan S; Liu J; Jiang H; Liu L
Mol Cancer; 2014 May; 13():133. PubMed ID: 24884809
[TBL] [Abstract][Full Text] [Related]
27. Stepwise targeting and responsive lipid-coated nanoparticles for enhanced tumor cell sensitivity and hepatocellular carcinoma therapy.
Li Y; Miao Y; Chen M; Chen X; Li F; Zhang X; Gan Y
Theranostics; 2020; 10(8):3722-3736. PubMed ID: 32206118
[No Abstract] [Full Text] [Related]
28. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F
Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584
[TBL] [Abstract][Full Text] [Related]
29. Thiolated chitosan nanoparticles for stable delivery and smart release of As
Song X; Wu J; Song W; Chen L; Zhang S; Ji H; Liu J; Gu J
Carbohydr Polym; 2023 Mar; 303():120462. PubMed ID: 36657859
[TBL] [Abstract][Full Text] [Related]
30. Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
Jiang H; Ma Y; Chen X; Pan S; Sun B; Krissansen GW; Sun X
Cancer Sci; 2010 Apr; 101(4):975-83. PubMed ID: 20219070
[TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro.
Wang GZ; Zhang W; Fang ZT; Zhang W; Yang MJ; Yang GW; Li S; Zhu L; Wang LL; Zhang WS; Liu R; Qian S; Wang JH; Qu XD
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1125-36. PubMed ID: 24756364
[TBL] [Abstract][Full Text] [Related]
32. Combinatorial Effect of Arsenic and Herbal Compounds in Telomerase-Mediated Apoptosis Induction in Liver Cancer.
Chaudhary A; Bhardwaj SK; Khan A; Srivastava A; Sinha KK; Ali M; Haque R
Biol Trace Elem Res; 2023 Jul; 201(7):3300-3310. PubMed ID: 36192614
[TBL] [Abstract][Full Text] [Related]
33. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy.
Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X
Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417
[TBL] [Abstract][Full Text] [Related]
34. Self-activated arsenic manganite nanohybrids for visible and synergistic thermo/immuno-arsenotherapy.
Zhai Y; Liu M; Yang T; Luo J; Wei C; Shen J; Song X; Ke H; Sun P; Guo M; Deng Y; Chen H
J Control Release; 2022 Oct; 350():761-776. PubMed ID: 36063961
[TBL] [Abstract][Full Text] [Related]
35. Arsenic trioxide-loaded nanoparticles enhance the chemosensitivity of gemcitabine in pancreatic cancer
Zhao Y; Yao H; Yang K; Han S; Chen S; Li Y; Chen S; Huang K; Lian G; Li J
Biomater Sci; 2022 Oct; 10(20):5989-6002. PubMed ID: 36052559
[TBL] [Abstract][Full Text] [Related]
36. Albumin conjugation promotes arsenic trioxide transport through alkaline phosphatase-associated transcytosis in MUC4 wildtype pancreatic cancer cells.
Chen K; Cheng X; Xue S; Chen J; Zhang X; Qi Y; Chen R; Zhang Y; Wang H; Li W; Cheng G; Huang Y; Xiong Y; Chen L; Mu C; Gu M
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128756. PubMed ID: 38092098
[TBL] [Abstract][Full Text] [Related]
37. Engineered tumor microvesicles modified by SP94 peptide for arsenic trioxide targeting drug delivery in liver cancer therapy.
Raza F; Zheng M; Zhong H; Su J; He B; Yuan WE; Qiu M
Biomater Adv; 2023 Dec; 155():213683. PubMed ID: 37925825
[TBL] [Abstract][Full Text] [Related]
38. Antitumor effect of arsenic trioxide in murine xenograft model.
Kito M; Matsumoto K; Wada N; Sera K; Futatsugawa S; Naoe T; Nozawa Y; Akao Y
Cancer Sci; 2003 Nov; 94(11):1010-4. PubMed ID: 14611680
[TBL] [Abstract][Full Text] [Related]
39. Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression.
Chen X; Huang Y; Chen H; Chen Z; Chen J; Wang H; Li D; Su Z
J Nanobiotechnology; 2022 Jan; 20(1):34. PubMed ID: 35033089
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation.
Zhai B; Jiang X; He C; Zhao D; Ma L; Xu L; Jiang H; Sun X
Tumour Biol; 2015 Apr; 36(4):2323-34. PubMed ID: 25416439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
